Financial News Discussion of BIIB - Biogen IDEC, Incorporated on The Call

Financial News for Biogen IDEC, Incorporated (BIIB)

BIIB	3/17/2010 4:00PM	52 Week Price Range	Market Capitalization	Dividend Yield	Recent Dividend
BIIB	$59.36	$41.75 — $59.85	$16.1 Billion	n/a	n/a

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Explore Why Ockham?

Quality Analysis

Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)

Crowd Sentiment

Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)

Financial News Slicing

With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)

Biogen IDEC, Inc. was discussed on The Call which was originally produced by CNBC on 2/5/2010

The Call hosted by Melissa Francis has an unbelievable following and has been known to really impact stocks with their news coverage. Today, Biogen IDEC, Incorporated was discussed on The Call.

Biogen IDEC, Incorporated is one of the thousands of companies that Ockham has news analytics on, and it was recently discussed on The Call.

The Motley Fool CAPS data suggests that investors believe Biogen IDEC, Incorporated will beat the market in the foreseeable future. As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, BIIB has been less covered in the news compared to the rest of our universe of stocks. At Ockham, our stance is currently Greatly Undervalued, which means we believe that value investors will really be interested in this stock at the current price level.

“Pharmaceuticals reporter mike huckman with breaking news on BIOGEN IDEC. This is ticker symbol BIIB and the fda is putting a new warning on the label for the company's drug for ...” The Call Feb 5, 2010 11:53 AM

Some important items we've observed:

Biogen IDEC, Incorporated BIIB has increased in price by 12.42% since it was mentioned on The Call.
Melissa Francis mentioned quite a few stocks, 11 individual companies to be exact. You can see the all company slices for The Call on the recap page.
As far as The Call on Friday, February 05, 2010, this is the only mention for Biogen IDEC, Incorporated.
There have been 9 mentions of Biogen IDEC, Incorporated BIIB since being mentioned on The Call on Friday, February 05, 2010. Ockham details all of the news on Biogen IDEC, Incorporated on our BIIB Financial News page.
The most active stock on The Call over the last 2 weeks has been Citigroup, Incorporated.